Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Join us November 12th for Webinar on Squamous Cell Carcinoma of Lung, Featuring Dr. David Spigel
Author
Howard (Jack) West, MD

We're thrilled to be working again with LUNGevity Foundation to bring you another webinar just in time for November as lung cancer awareness month. On Tuesday, November 12th, at 2 PM Eastern/11 AM Pacific, Dr. David Spigel from Sarah Cannon Cancer Center in Nashville, TN will lead us in a very timely discussion of current and future management issues in squamous cell non-small cell lung cancer (NSCLC), a subtype that comprises 20-25% of NSCLC but has historically been more known for treatments you don't offer than for specific treatment options that are especially appealing for it. Dr. Spigel is many things: a longtime friend of mine, as well as of GRACE, a terrific medical oncologist and lung cancer expert, and the Director of Clinical Research at the Sarah Cannon Cancer Center, where he has led many pivotal clinical trials that are shaping our understanding and treatment options for lung cancer over the years. He is also a gifted speaker who does a great job making complex ideas accessible.

Dr. David Spigel Dr. David Spigel

For the upcoming webinar, Dr. Spigel will provide a bit of historical perspective of what we have known about squamous cell NSCLC in terms of both its biology and clinical behavior. He will also review some of the optimal treatment approaches based on data from the past 1-2 decades, including explaining why certain treatments are specifically NOT favored for squamous NSCLC.  But the excitement is around some newer therapies, ranging from conventional chemotherapy to immune-based treatments to newly identified potential selective targets that may be highly relevant and effective for this historically underserved sizable minority of the lung cancer community.

Following his presentation that will last approximately 40-45 minutes, we'll welcome questions from our live audience. As always, our webinars are free and will be made available in edited podcast form after the program is completed, but please join us for the live event.  You can sign up here: come along and learn some new things about lung cancer during lung cancer awareness month.

Next Previous link

Previous PostNext Post

Related Content

Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.
Image
Terapias Dirigidas de Cancer de Pulmón 2024
Video
La Dra. Estelamari Rodríguez presenta información básica sobre el NSCLC EGFR+ y analiza la importancia de las pruebas de biomarcadores en el cáncer de pulmón y ofrece una descripción general de las opciones de tratamiento para la enfermedad EGFR+.  Para ver la playlist completa, de click aquí.        

Forum Discussions

Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...

Hi Bluebird,  Welcome to GRACE.  I'm sorry you're going through this scare and hope it's just inflammation or from an infection you didn't know you had. 

 

A CT would be...

Radiation + Brain Operation has just been discarded due to high risk. They will double Tagrisso dosis and then wait to see if it works, then try traditional Chemo. I would...

Hi and welcome to GRACE.  I'm sorry to know you are entering a new stage.  I'm not about to comment just now but wanted to let you know I see your...

Edit to say, we can't give advice but we can comment with views and facts.  :)

 

My first thought is to ask if she has been seen at a large...

Hi Barbro, Welcome to GRACE. I'm sorry you're worrying about this. We aren't able to give feedback on scan reports. Interpreting scan reports in this setting is not only unethical but...

Recent Comments

JOIN THE CONVERSATION
Tagrix FDA Approval
By mariachristian on
Hi Judy! It is so good to…
By JanineT GRACE … on
Tagrix vs Tagrisso
By Dipakchavan on
Hello Linda, my name is…
By AlexandraGBeneke on